204 related articles for article (PubMed ID: 36710949)
21. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
[TBL] [Abstract][Full Text] [Related]
22. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
Hwang YY; Mohty M; Chim CS
Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
[TBL] [Abstract][Full Text] [Related]
25. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.
Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR
Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361
[TBL] [Abstract][Full Text] [Related]
26. Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.
Riddell P; Vasudevan-Nampoothiri R; Ma J; Singer LG; Lipton JH; Juvet SC
Respir Res; 2021 Apr; 22(1):101. PubMed ID: 33827576
[TBL] [Abstract][Full Text] [Related]
27. Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.
Erdmann JH; Graf B; Blau IW; Fischer F; Timm G; Hemmati P; Arnold R; Penack O
Transpl Infect Dis; 2016 Jun; 18(3):354-60. PubMed ID: 26998687
[TBL] [Abstract][Full Text] [Related]
28. Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Grosicki S; Holowiecki J; Kuliczkowski K; Skotnicki A; Hellmann A; Kyrcz-Krzemien S; Dmoszynska A; Sułek K; Kloczko J; Jedrzejczak WW; Warzocha K; Zdziarska B; Wierzbowska A; Pluta A; Komarnicki M; Giebel S
Am J Hematol; 2015 Oct; 90(10):904-9. PubMed ID: 26149802
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.
Kasow KA; Krueger J; Srivastava DK; Li C; Barfield R; Leung W; Horwitz EM; Madden R; Woodard P; Hussain I; McCarville MB; Handgretinger R; Hale GA
Biol Blood Marrow Transplant; 2009 Apr; 15(4):490-5. PubMed ID: 19285637
[TBL] [Abstract][Full Text] [Related]
30. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
31. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
[TBL] [Abstract][Full Text] [Related]
33. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients.
Patel NR; Lee PS; Kim JH; Weinhouse GL; Koziel H
Chest; 2005 Apr; 127(4):1388-96. PubMed ID: 15821221
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up after allogeneic stem cell transplantation.
Hilgendorf I; Greinix H; Halter JP; Lawitschka A; Bertz H; Wolff D
Dtsch Arztebl Int; 2015 Jan; 112(4):51-8. PubMed ID: 25797423
[TBL] [Abstract][Full Text] [Related]
35. Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial.
Skaarud KJ; Hov JR; Hansen SH; Kummen M; Valeur J; Seljeflot I; Bye A; Paulsen V; Lundin KEA; Trøseid M; Tjønnfjord GE; Iversen PO
Sci Rep; 2021 Jun; 11(1):11593. PubMed ID: 34078971
[TBL] [Abstract][Full Text] [Related]
36. Impact of Body Mass Index on 5-Year Survival Rates in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Aoyama T; Notsu A; Ichimaru K; Hayashi K; Tsuji M; Yoshitsugu K; Fukaya M; Enami T; Ikeda T
Nutr Metab Insights; 2022; 15():11786388221128362. PubMed ID: 36225814
[TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
[TBL] [Abstract][Full Text] [Related]
38. Possible clinical outcomes using early enteral nutrition in individuals with allogeneic hematopoietic stem cell transplantation: A single-center retrospective study.
Iyama S; Tatsumi H; Shiraishi T; Yoshida M; Tatekoshi A; Endo A; Ishige T; Shiwa Y; Ibata S; Goto A; Nagashima K; Horiguchi H; Fujita C; Ikeda H; Takada K; Nobuoka T; Kamihara Y; Kikuchi S; Sato T; Ohnishi H; Yokota SI; Kobune M
Nutrition; 2021 Mar; 83():111093. PubMed ID: 33418488
[TBL] [Abstract][Full Text] [Related]
39. Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care Unit.
Díaz-Lagares C; Fox L; García-Roche A; Santafe M; Romera I; Barba P; Pacheco A; Roldán E; Plata-Menchaca E; Roca O; Pérez M; Valcarcel D; Ferrer R
Transplant Cell Ther; 2021 Oct; 27(10):865.e1-865.e7. PubMed ID: 34217846
[TBL] [Abstract][Full Text] [Related]
40. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
